$TMDX

4 stories mentioning TMDXUpdated 49d ago

Every FINWIRES story that references TMDX, newest first.

Update: TransMedics Shares Drop After Oppenheimer Downgrade Following Q1 Miss

(Updates with the latest stock price movement and Oppenheimer downgrade in the headline and the first paragraph.)TransMedics (TMDX) shares fell past 25% in afternoon trading on Wednesday after Oppenheimer downgraded the stock to market perform from outperform, a day after the company posted lower-than-expected Q1 results.The company reported Q1 adjusted net income late Tuesday of $0.30 per diluted share, down from $0.74 a year earlier.Analysts polled by FactSet expected $0.60.Revenue in the three months ended March 31 rose to $173.9 million from $143.5 million a year earlier.Analysts surveyed by FactSet expected $174.5 million.The company reiterated its 2026 revenue guidance of $727 million to $757 million. Analysts expect $740.2 million.Price: $71.15, Change: $-23.78, Percent Change: -25.05%

$TMDX

Wire54d ago

Needham Adjusts Price Target on TransMedics Group to $142 From $174, Maintains Buy Rating

TransMedics Group (TMDX) has an average rating of overweight and mean price target of $121.10, according to analysts polled by FactSet.(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://www..com/contact-us)Price: $75.21, Change: $-19.72, Percent Change: -20.77%

$TMDX

Research54d ago

Oppenheimer Downgrades TransMedics Group to Market Perform From Outperform

TransMedics Group (TMDX) has an average rating of overweight and mean price target of $126.50, according to analysts polled by FactSet.(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://www..com/contact-us)

$TMDX

Wire61d ago

TransMedics Group Agrees to Invest in PAD Aviation for European Transplant Logistics Network

TransMedics Group (TMDX) said Wednesday it agreed to invest in Germany-based private aviation operator PAD Aviation to establish a dedicated air and ground logistics network for organ transplants in Europe.The project will support the firm's OCS perfusion platform and clinical services to help expand access to donor organs and increase transplant volumes across the European Union, the company said.Management anticipates closing the deal later in 2026, subject to standard regulatory approvals and closing conditions, TransMedics said.Shares of the company were down 1.9% in Wednesday trading.Price: $99.63, Change: $-1.63, Percent Change: -1.61%

$TMDX

Track with the FINWIRES app suite

FolioX

Track TMDX in your portfolio

WheelAI

Analyze TMDX options with the wheel strategy

StockInsider

See market sentiment on TMDX